RightFit
Not yet recruitingNot applicable

HomeCare Medication Management for People With Dementia

Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
65 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 12 months
  • Procedures mentioned: Pills, Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "One group will use the HomeCare system, while the other group will continue using standard medication management methods, such as pill bottles or blister packs."
  • "Participants will be followed for 12 months."
  • "Caregivers will also participate in surveys and study assessments."
  • "Participants assigned to the control group will continue using traditional medication-management methods, including pill bottles or blister packs."
  • "The primary objective is to evaluate medication adherence over 12 months."
  • "Caregivers in both study groups will receive study-related training and will complete surveys and other assessments related to caregiver burden, quality of life, medication-management activities, and their experience supporting the participant."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether HomeCare helps adults age 65 and older with dementia, including Alzheimer's disease, take their medicines as directed. HomeCare is an internet-connected device that gives out medicine, tracks its use, and alerts caregivers. Over 12 months, the study will compare HomeCare with usual methods, such as pill bottles or blister packs.

This study will evaluate whether the HomeCare medication management system can improve medication adherence and related outcomes for adults age 65 and older living with dementia, Alzheimer's disease, or related dementias. HomeCare is an internet-connected medication management device that can automate medication dispensing, monitor medication use, and provide alerts to caregivers. The system is integrated with a Pharmacy Distribution System designed to track medications from pharmacy delivery through use in the home. A total of 120 participants with dementia will be randomly assigned to one of two groups. One group will use the HomeCare system, while the other group will continue using standard medication management methods, such as pill bottles or blister packs. Participants will be followed for 12 months. The main outcome is medication adherence. The study will also examine hospitalizations and emergency room visits, cognitive function, caregiver burden, quality of life, satisfaction, and changes in medication-management behavior. Caregivers will also participate in surveys and study assessments. The study is intended to determine whether HomeCare can improve medication management and support both people living with dementia and their caregivers.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • You are age 65 or older.
  • You have been diagnosed with dementia, Alzheimer's disease, or a related dementia using standard guidelines.
  • You can agree to join after learning about the study, or someone legally allowed to decide for you can agree.
  • You have access to a smartphone, tablet, or computer with internet.
  • You can communicate in English or Spanish.

Who can't join

  • You have major health problems that could affect participation, or severe problems with memory and thinking.
  • You have a history of severe mental illness or a disorder involving alcohol or drug misuse.
  • You recently joined another clinical trial focused on thinking, memory, or dementia.
  • You are unwilling or unable to follow the study steps.
  • You live in a long-term care facility or another care setting that may limit use of HomeCare.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Age 65 years or older. * Living with dementia, Alzheimer's Disease, or Alzheimer's Disease Related Dementias (AD/ADRD) according to standardized diagnostic criteria. * Capable of providing informed consent or have a legally authorized representative available to consent on their behalf. * Access to a smartphone, tablet, or computer with internet connectivity. Able to communicate in either English or Spanish. Exclusion Criteria: * Significant comorbidities or medical conditions that could interfere with participation or severe cognitive function. * History of severe psychiatric illness or substance abuse disorder. * Recent participation in other clinical trials targeting cognition or dementia. * Unwillingness or inability to comply with study procedures. * Residence in a long-term care facility or institutional setting that may limit access to the home-based study intervention.

Study sites (1)

CA